A patient is pictured before a mammography in France in 2017
From
To
A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't seen major drug ad…
WEDNESDAY, May 21, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved the humanized monoclonal antibody, Zynyz, (reti…
TUESDAY, April 15, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as …